The Development of Health Expenditures in the Social Health Insurance (SHI) in Germany Until 2050 - Remaining Challenge for German Health Policy

2010 ◽  
Author(s):  
Dirk Sauerland ◽  
Ansgar Wübker
2021 ◽  
Vol 6 (2) ◽  
pp. e004117
Author(s):  
Aniqa Islam Marshall ◽  
Kanang Kantamaturapoj ◽  
Kamonwan Kiewnin ◽  
Somtanuek Chotchoungchatchai ◽  
Walaiporn Patcharanarumol ◽  
...  

Participatory and responsive governance in universal health coverage (UHC) systems synergistically ensure the needs of citizens are protected and met. In Thailand, UHC constitutes of three public insurance schemes: Civil Servant Medical Benefit Scheme, Social Health Insurance and Universal Coverage Scheme. Each scheme is governed through individual laws. This study aimed to identify, analyse and compare the legislative provisions related to participatory and responsive governance within the three public health insurance schemes and draw lessons that can be useful for other low-income and middle-income countries in their legislative process for UHC. The legislative provisions in each policy document were analysed using a conceptual framework derived from key literature. The results found that overall the UHC legislative provisions promote citizen representation and involvement in UHC governance, implementation and management, support citizens’ ability to voice concerns and improve UHC, protect citizens’ access to information as well as ensure access to and provision of quality care. Participatory governance is legislated in 33 sections, of which 23 are in the Universal Coverage Scheme, 4 in the Social Health Insurance and none in the Civil Servant Medical Benefit Scheme. Responsive governance is legislated in 24 sections, of which 18 are in the Universal Coverage Scheme, 2 in the Social Health Insurance and 4 in the Civil Servant Medical Benefit Scheme. Therefore, while several legislative provisions on both participatory and responsive governance exist in the Thai UHC, not all schemes equally bolster citizen participation and government responsiveness. In addition, as legislations are merely enabling factors, adequate implementation capacity and commitment to the legislative provisions are equally important.


The Lancet ◽  
2015 ◽  
Vol 386 (10002) ◽  
pp. 1484-1492 ◽  
Author(s):  
Qingyue Meng ◽  
Hai Fang ◽  
Xiaoyun Liu ◽  
Beibei Yuan ◽  
Jin Xu

2017 ◽  
Vol 15 (1) ◽  
pp. 85-87
Author(s):  
Vishnu Prasad Sapkota ◽  
Umesh Prasad Bhusal

Nepal is pursuing Social Health Insurance as a way of mobilizing revenues to achieve Universal Health Coverage. The Social Health Insurance governance encourages service providers to maintain quality and efficiency in services provision by practicing strategic purchasing. Social Health Security Programme is a social protection program which aspires to achieve the goals of Social Health Insurance. Social Health Security Development Committee needs to consider following experiences to function as a strategic purchaser. The Social Health Security Development Committee need to be an independent body instead of falling under Ministry of Health. Similarly, purchasing of health services needs to be made strategic, i.e., Social Health Security Development Committee should use its financial power to guide the provider behavior that will eventually contribute to achieving the goals of quality and efficiency in service provision. The other social health security funds should be merged with Social Health Security Development Committee and develop a single national fund. Finally, the state has to regulate and monitor the performance of the SHI agency.


1997 ◽  
Vol 27 (106) ◽  
pp. 29-53
Author(s):  
Tomas Steffens

While public health insurance (PHI) fees keep increasing, it is not the material structural problems of the PHI system but strategies towards the privatization of sickness risks which deterrnine the discussion in health policy. This article analyzes the effects of an introduction of free-market steering mechanisms on the planning principles of a social health insurance.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Afschin Gandjour

Abstract Background Health care systems around the world struggle with high prices for new cancer drugs. The purpose of this study was to conduct a gedankenexperiment and calculate how much health expenditures would change if a cure for cancer through pharmaceutical treatment were made available. The cancer cure was conceived to eliminate both cancer deaths and the underlying morbidity burden of cancer. Furthermore, the cure was hypothesized to arrive in incremental steps but at infinitesimally small time intervals (resulting, effectively, in an immediate cure). Methods The analysis used secondary data and was conducted from the viewpoint of the German social health insurance. As its underlying method, it used a cause-elimination life-table approach. To account for the age distribution of the population, the study weighted age-specific increases in remaining life expectancy by age-specific population sizes. It considered drug acquisition costs as well as savings and life extension costs from eliminating cancer. All cancer drugs that underwent a mandatory early benefit assessment in Germany between 2011 and 2015/16 and were granted an added benefit were included. Data on age- and gender-specific probabilities of survival, population sizes, causes of death, and health expenditures, as well as data on cancer costs were taken from the German Federal Office of Statistics and the German Federal Social Insurance Office. Results Based on the cause-elimination life-table approach and accounting for the age structure of the German population, curing cancer in Germany yields an increase in average remaining life expectancy by 2.66 life years. Based on the current incremental cost-effectiveness ratio of new cancer drugs, which is on average €101,493 per life year gained (€39,751/0.39 life years), the German social health insurance would need to pay €280,497 per insuree to eliminate cancer. Dividing this figure by current average remaining lifetime health expenditures yields a ratio of 2.07, which represents a multiplier of current health expenditures. Conclusions Eliminating cancer at current price levels would more than triple total health expenditures in Germany. As the current price of a cure requires a drastic reduction of non-health consumption, it appears that current prices for cancer drugs already on the market (i.e., small steps towards a cure) need careful reconsideration.


2020 ◽  
Vol 10 ◽  
pp. 204-223
Author(s):  
Kazuo Tanne

Current status of clinical orthodontics in European and American countries was examined by means of a questionnaire survey through internet. In the European and American countries, most popular technique in daily orthodontic practice is preadjusted straight wire edgewise technique. In major developed countries in Europe and America, the treatment fee is considerably high, whereas the fee is relatively low in the countries under development and/or after economic crisis. Rate of non-extraction treatment among all the cases treated with multi-bracket appliances is significantly higher in Europe and America than in Asia except in a few countries. In the European and American countries, treatment system for jaw deformity patients is well developed with higher availability of the social health insurance than in Asia. The maximum CLP prevalence of 0.200 is found in Germany and Austria and the mean is around 0.140 or one to 700 births. In general, CLP treatment is covered by social health insurance in European and American countries. In Europe and America, lingual orthodontic technique has not become popular because patients never want to hide orthodontic appliance. Higher cost of lingual appliance and lack in information and technical skills may be the reasons of less frequent use of lingual appliance. Many interviewees replied that usage of TADs has not become so popular in USA and Canada as compared to that in Asia. In another word, the initial fascination with TADs wore off and are now used in selected patients as needed. This may be due to more harmonious maxillofacial structure with longer and wider dentitions in Caucasians which also results in higher rate of non-extraction treatment with multibracket appliances in European and American countries.


2019 ◽  
Vol 31 (7) ◽  
pp. 584-593
Author(s):  
Sumudu Karunaratna ◽  
Thushara Ranasinghe ◽  
Nadeeka Chandraratne ◽  
Amala De Silva

Agrahara is a mandatory social health insurance scheme providing coverage mostly for inpatient care for the public sector employees in Sri Lanka. For the 20 years of its’ existence there is no clear evidence on its’ effectiveness in reducing the financial burden due to ill health. We conducted a cross-sectional study among public sector employees (n = 500) in one district. Utilizing outpatient care was associated with a higher incidence of catastrophic health expenditure (29.4%) than utilizing inpatient care (7.2%). The poorest income quintile was at higher odds of facing catastrophic health expenditure than the richest. The social health insurance scheme with its lower utilization rate (38%) had only been able to protect 25% of households from catastrophe. Thus, alternative options to reduce out-of-pocket expenditure of outpatient care are needed. To improve the utilization rates of the social health insurance scheme, a wider benefit package, a cost-efficient delivery of government inpatient care, and improving awareness of the social health insurance policy are suggested.


Sign in / Sign up

Export Citation Format

Share Document